ARDS
Aridis Pharmaceuticals Inc. Common Stock
ARDS
ARDS
Delisted
ARDS was delisted on the 18th of July, 2023.
6 hedge funds and large institutions have $725K invested in Aridis Pharmaceuticals Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
6
Holders Change
+6
Holders Change %
–
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Goldman Sachs
New York
| $370K | 28,348 | +28,348 | New |
|
2
Millennium Management
New York
| $306K | 23,585 | +23,585 | New |
|
3
UBS Group
Zurich,
Switzerland
| $24K | 1,809 | +1,809 | New |
|
|
SPIA
4
Steward Partners Investment Advisory
New York
| $13K | 1,000 | +1,000 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $8K | 625 | +625 | New |
|
6
Wells Fargo
San Francisco,
California
| $4K | 300 | +300 | New |
|
|
CFGS
7
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|